Difference between revisions of "Lymphoepithelioma-like carcinoma of the urinary bladder"

Jump to navigation Jump to search
no edit summary
Line 42: Line 42:
**Central nuclei +/- small/indistinct nucleoli.  
**Central nuclei +/- small/indistinct nucleoli.  
**Surrounded by a prominent lymphoid component - '''key feature'''.
**Surrounded by a prominent lymphoid component - '''key feature'''.
*+/-[[Urothelial carcinoma in situ]].


DDx:
DDx:
Line 60: Line 61:
</ref>
</ref>
*[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2881438/figure/F0003/ LELC of the urinary bladder - high mag. (nih.gov)].<ref name=pmid19847088/>
*[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2881438/figure/F0003/ LELC of the urinary bladder - high mag. (nih.gov)].<ref name=pmid19847088/>
==IHC==
Features:<ref name=pmid21383609/>
*p53 +ve/-ve.
*CK20 -ve.
*TTF-1 -ve.
*CD30 -ve.
*CK34betaE12 +ve (+ve in 75% of cases).
*CK7 +ve/-ve (+ve in ~60% of cases).
*p63 +ve/-ve (+ve in ~50% of cases).


==See also==
==See also==
48,830

edits

Navigation menu